Avo vs MedPearl (2026)
Two guidance products delivered inside the record, built from different starting points. Avo digitises medical society guidelines and calculators into decision support a health system can extend with its own protocols, with the deepest record system integration in this segment. MedPearl was built inside a fifty one hospital system and used there since 2022, aimed narrowly at the primary care referral question, with content oversight documented more thoroughly than almost anything in this index. Avo is the broader library; MedPearl is the sharper workflow with real operating history behind it. Neither publishes a security attestation or a mechanism for noticing when a guideline underneath either product has been superseded, which is the failure both share.
- Recommendations are anchored to named medical society guidelines, so a clinician and a risk committee can see exactly what standard the advice came from.
- The record system integration is the deepest in this segment and clears a marketplace credential test rather than resting on partnership language.
- Health systems can add their own protocols, turning institutional policy into something that reaches the point of care.
- It was built inside a fifty one hospital system and has been in use there since 2022, so the workflow was designed against real referral and specialty access problems.
- Content oversight is documented in more detail than almost anything in this index, and patient data surfaced from the record is stated not to be stored.
- The job is deliberately narrow, supporting the primary care question about whether and where to refer.
This comparison is published by AI Health Index, an independent research platform that compares healthcare AI vendors objectively. Avo and MedPearl are each graded against the same capability taxonomy, from each vendor's own public materials and the regulatory record, under the AI Health Index verification standard. No vendor pays for placement, and no vendor has reviewed this page. How this evidence is graded
Plain facts
| Fact | Avo | MedPearl |
|---|---|---|
| Primary category | Clinical Decision Support | Clinical Decision Support |
| Website | avomd.com | medpearl.com |
Side by Side
Each record in one paragraph
Written to be quoted whole. Each paragraph states what the AI Health Index verified about the vendor, with the caveats attached. Generated from this pair’s live capability grades, so it moves when a grade moves.
The AI Health Index awards Avo its top capability grade on EHR and Interoperability Depth and Setting and Specialty Coverage. Set against MedPearl, Avo grades higher on several axes, including AI Centrality, Security Certifications and Trust Center and AI Governance and Bias Disclosure. Its thinnest published disclosure sits on AI Liability and Recourse. Grades reflect evidence the AI Health Index could verify at the last review, so a low grade records disclosure the vendor has not published rather than a capability it has been shown to lack.
Source: AI Health Index, August 2026
The AI Health Index records no top capability grade for MedPearl on any axis it scores. Set against Avo, MedPearl grades higher on Autonomy and Oversight Model and Model Supply Chain Disclosure. Its thinnest published disclosure sits on AI Liability and Recourse. Grades reflect evidence the AI Health Index could verify at the last review, so a low grade records disclosure the vendor has not published rather than a capability it has been shown to lack.
Source: AI Health Index, August 2026
Questions buyers ask
Should we choose Avo or MedPearl?
On the axes where the AI Health Index separates them, Avo grades higher on several axes, including AI Centrality, Security Certifications and Trust Center and AI Governance and Bias Disclosure, and MedPearl grades higher on Autonomy and Oversight Model and Model Supply Chain Disclosure. Avo leads on the greater share of scored axes, but the split means the decision turns on which constraint is binding rather than on an overall winner.
Where do Avo and MedPearl differ most?
The widest separation the AI Health Index records between Avo and MedPearl is on Setting and Specialty Coverage, where Avo grades A and MedPearl grades C. That axis sits in the Commercial group, so it should carry the most weight for a buyer whose binding constraint is contracting, scope and what the price actually covers.
Where do Avo and MedPearl grade the same?
The AI Health Index grades Avo and MedPearl the same on several axes, including Model and Technology Transparency, Clinical and Operational Evidence and AI Safety and PHI Stewardship. Neither holds an advantage the index can evidence on those axes, so they should not carry weight in a selection between these two.
What have Avo and MedPearl not disclosed?
At the last review, at least one of Avo and MedPearl published thin or absent detail on AI Liability and Recourse. The AI Health Index treats an absent disclosure as a gap in the public record rather than a failure of the product, so these are the axes to get in writing during diligence instead of inferring from the grade.
Related comparisons
Other published head to head assessments involving these vendors or their closest peers. The full set for this category is on the Clinical Decision Support page.
Both deliver guidance inside the record and neither publishes a security attestation, a health privacy statement or business associate terms, which is a wide gap for products at the point of care. Neither publishes pricing. The shared failure mode is a superseded guideline nobody noticed, and neither publishes a review cycle or any drift detection mechanism, so ask each what triggers a retirement and who owns the content calendar.